NGM·Healthcare·$234M·#42 / 520 in Healthcare
OBIO Orchestra BioMed Holdings, Inc.
73SOLID
CATEGORY BREAKDOWN
GROWTH100
QUALITY100
STABILITY40
VALUATION60
GOVERNANCE64
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+1169.2%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
99.4%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
9 months
23
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
29.8%
75
< 25% strong
Price / Sales
Market cap relative to trailing revenue
7.0x
60
< 3x strong
Rule of 40
Growth rate plus operating margin
1014
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
27.3%
96
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+52.7%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE OBIO WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when OBIO's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.